BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28008202)

  • 1. Investigation of single-nucleotide variants in MBD5 associated with autism spectrum disorders and schizophrenia phenotypes.
    Ishizuka K; Kimura H; Yoshimi A; Banno M; Kushima I; Uno Y; Okada T; Mori D; Aleksic B; Ozaki N
    Nagoya J Med Sci; 2016 Dec; 78(4):465-474. PubMed ID: 28008202
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder.
    Talkowski ME; Mullegama SV; Rosenfeld JA; van Bon BW; Shen Y; Repnikova EA; Gastier-Foster J; Thrush DL; Kathiresan S; Ruderfer DM; Chiang C; Hanscom C; Ernst C; Lindgren AM; Morton CC; An Y; Astbury C; Brueton LA; Lichtenbelt KD; Ades LC; Fichera M; Romano C; Innis JW; Williams CA; Bartholomew D; Van Allen MI; Parikh A; Zhang L; Wu BL; Pyatt RE; Schwartz S; Shaffer LG; de Vries BB; Gusella JF; Elsea SH
    Am J Hum Genet; 2011 Oct; 89(4):551-63. PubMed ID: 21981781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic exome sequencing identifies a heterozygous MBD5 frameshift mutation in a family with intellectual disability and epilepsy.
    Han JY; Lee IG; Jang W; Kim M; Kim Y; Jang JH; Park J
    Eur J Med Genet; 2017 Oct; 60(10):559-564. PubMed ID: 28807762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of Rare Single-Nucleotide PCDH15 Variants in Schizophrenia and Autism Spectrum Disorders.
    Ishizuka K; Kimura H; Wang C; Xing J; Kushima I; Arioka Y; Oya-Ito T; Uno Y; Okada T; Mori D; Aleksic B; Ozaki N
    PLoS One; 2016; 11(4):e0153224. PubMed ID: 27058588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare single-nucleotide DAB1 variants and their contribution to Schizophrenia and autism spectrum disorder susceptibility.
    Nawa Y; Kimura H; Mori D; Kato H; Toyama M; Furuta S; Yu Y; Ishizuka K; Kushima I; Aleksic B; Arioka Y; Morikawa M; Okada T; Inada T; Kaibuchi K; Ikeda M; Iwata N; Suzuki M; Okahisa Y; Egawa J; Someya T; Nishimura F; Sasaki T; Ozaki N
    Hum Genome Var; 2020 Nov; 7(1):37. PubMed ID: 33298905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders.
    Ishizuka K; Fujita Y; Kawabata T; Kimura H; Iwayama Y; Inada T; Okahisa Y; Egawa J; Usami M; Kushima I; Uno Y; Okada T; Ikeda M; Aleksic B; Mori D; Someya T; Yoshikawa T; Iwata N; Nakamura H; Yamashita T; Ozaki N
    Transl Psychiatry; 2017 Aug; 7(8):e1184. PubMed ID: 28763059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel MBD5 mutation in an intellectually disabled adult female patient with epilepsy: Suggestive of early onset dementia?
    Verhoeven W; Egger J; Kipp J; Verheul-Aan de Wiel J; Ockeloen C; Kleefstra T; Pfundt R
    Mol Genet Genomic Med; 2019 Aug; 7(8):e849. PubMed ID: 31290275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable phenotype expression in a family segregating microdeletions of the
    Woodbury-Smith M; Nicolson R; Zarrei M; Yuen RKC; Walker S; Howe J; Uddin M; Hoang N; Buchanan JA; Chrysler C; Thompson A; Szatmari P; Scherer SW
    NPJ Genom Med; 2017 May; 2():. PubMed ID: 28649445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expanding role of MBD genes in autism: identification of a MECP2 duplication and novel alterations in MBD5, MBD6, and SETDB1.
    Cukier HN; Lee JM; Ma D; Young JI; Mayo V; Butler BL; Ramsook SS; Rantus JA; Abrams AJ; Whitehead PL; Wright HH; Abramson RK; Haines JL; Cuccaro ML; Pericak-Vance MA; Gilbert JR
    Autism Res; 2012 Dec; 5(6):385-97. PubMed ID: 23055267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of ultra-rare disruptive variants in voltage-gated calcium channel-encoding genes in Japanese samples of schizophrenia and autism spectrum disorder.
    Wang C; Horigane SI; Wakamori M; Ueda S; Kawabata T; Fujii H; Kushima I; Kimura H; Ishizuka K; Nakamura Y; Iwayama Y; Ikeda M; Iwata N; Okada T; Aleksic B; Mori D; Yoshida T; Bito H; Yoshikawa T; Takemoto-Kimura S; Ozaki N
    Transl Psychiatry; 2022 Feb; 12(1):84. PubMed ID: 35220405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities.
    Hodge JC; Mitchell E; Pillalamarri V; Toler TL; Bartel F; Kearney HM; Zou YS; Tan WH; Hanscom C; Kirmani S; Hanson RR; Skinner SA; Rogers RC; Everman DB; Boyd E; Tapp C; Mullegama SV; Keelean-Fuller D; Powell CM; Elsea SH; Morton CC; Gusella JF; DuPont B; Chaubey A; Lin AE; Talkowski ME
    Mol Psychiatry; 2014 Mar; 19(3):368-79. PubMed ID: 23587880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended spectrum of MBD5 mutations in neurodevelopmental disorders.
    Bonnet C; Ali Khan A; Bresso E; Vigouroux C; Béri M; Lejczak S; Deemer B; Andrieux J; Philippe C; Moncla A; Giurgea I; Devignes MD; Leheup B; Jonveaux P
    Eur J Hum Genet; 2013 Dec; 21(12):1457-61. PubMed ID: 23422940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia.
    Ishizuka K; Yoshida T; Kawabata T; Imai A; Mori H; Kimura H; Inada T; Okahisa Y; Egawa J; Usami M; Kushima I; Morikawa M; Okada T; Ikeda M; Branko A; Mori D; Someya T; Iwata N; Ozaki N
    J Neurodev Disord; 2020 Sep; 12(1):25. PubMed ID: 32942984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional consequences of MBD5 disruption in mouse brain and CRISPR-derived neurons.
    Seabra CM; Aneichyk T; Erdin S; Tai DJC; De Esch CEF; Razaz P; An Y; Manavalan P; Ragavendran A; Stortchevoi A; Abad C; Young JI; Maciel P; Talkowski ME; Gusella JF
    Mol Autism; 2020 Jun; 11(1):45. PubMed ID: 32503625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Molecular Aspects of MBD5-Associated Neurodevelopmental Disorder (MAND).
    Mullegama SV; Elsea SH
    Eur J Hum Genet; 2016 Aug; 24(9):1235-43. PubMed ID: 27222293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MBD5-related intellectual disability in a Vietnamese child.
    Le TNU; Ha TMT
    Am J Med Genet A; 2021 Apr; 185(4):1321-1323. PubMed ID: 33427406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The methyl binding domain containing protein MBD5 is a transcriptional regulator responsible for 2q23.1 deletion syndrome.
    Walz K; Young JI
    Rare Dis; 2014; 2(1):e967151. PubMed ID: 26942102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Genetic Variant in
    Martins M; Oliveira AR; Martins S; Vieira JP; Perdigão P; Fernandes AR; de Almeida LP; Palma PJ; Sequeira DB; Santos JMM; Duque F; Oliveira G; Cardoso AL; Peça J; Seabra CM
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the periphery to centre stage: de novo single nucleotide variants play a key role in human genetic disease.
    Ku CS; Tan EK; Cooper DN
    J Med Genet; 2013 Apr; 50(4):203-11. PubMed ID: 23396985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation.
    Pinto AM; Bianciardi L; Mencarelli MA; Imperatore V; Di Marco C; Furini S; Suppiej A; Salviati L; Tenconi R; Ariani F; Mari F; Renieri A
    Brain Dev; 2016 Jun; 38(6):590-6. PubMed ID: 26754451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.